Association of HMG-CoA reductase inhibitors with neuropathyBACKES, James M; HOWARD, Patricia A.The Annals of pharmacotherapy. 2003, Vol 37, Num 2, pp 274-278, issn 1060-0280, 5 p.Article

Simvastatin-fluconazole causing rhabdomyolysisSHAUKAT, Aasma; BENEKLI, Mustafa; VLADUTIU, Georgirene D et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 7-8, pp 1032-1035, issn 1060-0280, 4 p.Article

Statin-fibrate combination therapy for hyperlipidaemia: a reviewWIERZBICKI, A. S; MIKHAILIDIS, D. P; WRAY, R et al.Current medical research and opinion. 2003, Vol 19, Num 3, pp 155-168, issn 0300-7995, 14 p.Article

Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantationASBERG, Anders; HOLDAAS, Hallvard; JARDINE, Alan G et al.Clinical transplantation. 2003, Vol 17, Num 4, pp 385-390, issn 0902-0063, 6 p.Article

Considerations for supplementing with coenzyme Q₁₀ during statin therapyBARENHOLTZ LEVY, Hedva; KOHLHAAS, Heather K.The Annals of pharmacotherapy. 2006, Vol 40, Num 2, pp 290-294, issn 1060-0280, 5 p.Article

Acute vasodilator effects of HMG-CoA reductase inhibitors: Involvement of P13-kinase/Akt pathway and Kv channelsMUKAI, Yasushi; SHIMOKAWA, Hiroaki; MATOBA, Tetsuya et al.Journal of cardiovascular pharmacology. 2003, Vol 42, Num 1, pp 118-124, issn 0160-2446, 7 p.Article

Statin induced myotoxicity : The lactone forms are more potent than the acid forms in human skeletal muscle cells in uitroSKOTTHEIM, Ine Blankenberg; GEDDE-DAHL, Ane; HEJAZIFAR, Solmaz et al.European journal of pharmaceutical sciences. 2008, Vol 33, Num 4-5, pp 317-325, issn 0928-0987, 9 p.Article

Inhibitory effects of statins on human monocarboxylate transporter 4KOBAYASHI, Masaki; OTSUKA, Yukio; ITAGAKI, Shirou et al.International journal of pharmaceutics. 2006, Vol 317, Num 1, pp 19-25, issn 0378-5173, 7 p.Article

Effect of statin therapy on leptin levels in patients with coronary heart diseaseSUN, Yan-Ming; JIA LI; YING LUAN et al.Peptides (New York, NY. 1980). 2010, Vol 31, Num 6, pp 1205-1207, issn 0196-9781, 3 p.Article

Factors related to adherence to statin therapyMCGINNIS, Brandy; OLSON, Kari L; MAGID, David et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 11, pp 1805-1811, issn 1060-0280, 7 p.Article

Development of predictive quantitative retention-activity relationship models of HMG-CoA reductase inhibitors by biopartitioning micellar chromatographyWANG, Shu-Rong; YU CHEN; WU, Li-Ping et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 46, Num 2, pp 243-249, issn 0731-7085, 7 p.Article

Simvastatin treatment induces morphology alterations and apoptosis in murine cochlear neuronal cellsPARK, Do-Sim; SO, Hong-Seob; LEE, Jeong-Han et al.Acta oto-laryngologica. 2009, Vol 129, Num 2, pp 166-174, issn 0001-6489, 9 p.Article

Statins and progression of calcified aortic stenosisCHUA, Doson; KALB, Kelli.The Annals of pharmacotherapy. 2006, Vol 40, Num 12, pp 2195-2199, issn 1060-0280, 5 p.Article

Photostability of pitavastatin―A novel HMG-CoA reductase inhibitorGROBELNY, Pawel; VIOLA, Giampietro; VEDALDI, Daniela et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 50, Num 4, pp 597-601, issn 0731-7085, 5 p.Conference Paper

Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitroNISHIMOTO, Tomoyuki; AMANO, Yuichiro; TOZAWA, Ryuichi et al.British journal of pharmacology. 2003, Vol 139, Num 5, pp 911-918, issn 0007-1188, 8 p.Article

Potential use of HMG-CoA reductase inhibitors (statins) as radioprotective agentsFRITZ, Gerhard; HENNINGER, Christian; HUELSENBECK, Johannes et al.British medical bulletin. 2011, Vol 97, pp 17-26, issn 0007-1420, 10 p.Article

PitavastatinMUKHTAR, R. Y. A; REID, J; RECKLESS, J. P. D et al.International journal of clinical practice (Esher). 2005, Vol 59, Num 2, pp 239-252, issn 1368-5031, 14 p.Article

Morelloflavone from Garcinia dulcis as a Novel Biflavonoid Inhibitor of HMG-CoA ReductaseTUANSULONG, Ku-Aida; HUTADILOK-TOWATANA, Nongporn; MAHABUSARAKAM, Wilawan et al.PTR. Phytotherapy research. 2011, Vol 25, Num 3, pp 424-428, issn 0951-418X, 5 p.Article

Combination of clopidogrel and statins : A hypothetical interaction or therapeutic dilemma?TAFRESHI, Mohammad J; ZAGNONI, Laura G; GENTRY, Elmer J et al.Pharmacotherapy. 2006, Vol 26, Num 3, pp 388-394, issn 0277-0008, 7 p.Article

HMG-CoA-reductase inhibitors and neuropathy : Reports to the netherlands pharmacovigilance centreDE LANGEN, J. J; VAN PUIJENBROEK, E. P.Netherlands journal of medicine. 2006, Vol 64, Num 9, pp 334-338, issn 0300-2977, 5 p.Article

The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal DialysisFA MEE DOH; CHANG, Tae-Ik; HAN, Dae-Suk et al.Cardiovascular drugs and therapy. 2012, Vol 26, Num 6, pp 501-509, issn 0920-3206, 9 p.Article

Pitavastatin: A New HMG-CoA Reductase InhibitorWENSEL, Terri M; WALDROP, Bruce A; WENSEL, Brian et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 3, pp 507-514, issn 1060-0280, 8 p.Article

65-jähriger Patient mit gelb-orange farbenen Papeln an beiden Unterarmen = 65-year-old man with yellow-orange papules on both forearmsSTREIT, E; HELMBOLD, P.Der Hautarzt. 2009, Vol 60, Num 10, pp 834-837, issn 0017-8470, 4 p.Article

Successful strategy to improve the specificity of electronic statin-drug interaction alertsSEIDLING, Hanna Marita; STORCH, Caroline Henrike; BERTSCHE, Thilo et al.European journal of clinical pharmacology. 2009, Vol 65, Num 11, pp 1149-1157, issn 0031-6970, 9 p.Article

Preprocedural statin therapy in percutaneous coronary interventionCAHOON, William D; CROUCH, Michael A.The Annals of pharmacotherapy. 2007, Vol 41, Num 10, pp 1687-1693, issn 1060-0280, 7 p.Article